CD34, as a powerful pan-endothelial cell marker, is widely expressed in mature vascular endothelial cells and has garnered extensive interest among clinicians in clinical practice, especially in the fields of cardiovascular and cerebrovascular diseases and cancer [20]. The gene discussed is CD34; the disease is cancer.